# Community Based Trial for AMEVIVE®

> **NCT00168753** · PHASE4 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 114 (actual)

## Conditions studied

- Moderate to Severe Chronic Plaque Psoriasis

## Interventions

- **DRUG:** Alefacept

## Key facts

- **NCT ID:** NCT00168753
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2005-03
- **Final completion:** 2005-03
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2014-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00168753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00168753, "Community Based Trial for AMEVIVE®". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00168753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*